Menu

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma

Article |

hazelsailor 1mo ago
Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma

Biogen said on Monday it had agreed to pay up to $850 million to acquire exclusive rights in Greater ​China to an experimental immune disease treatment from...

Comments (0)

Newest

No comments yet.